SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 42 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $359,410 | -59.2% | 192,198 | -45.2% | 0.00% | – |
| Q2 2023 | $881,015 | +14.2% | 351,002 | -20.4% | 0.00% | – |
| Q1 2023 | $771,556 | +227.0% | 440,889 | +694.2% | 0.00% | – |
| Q4 2022 | $235,922 | +227.7% | 55,511 | -8.6% | 0.00% | – |
| Q3 2022 | $72,000 | +111.8% | 60,740 | +76.6% | 0.00% | – |
| Q2 2022 | $34,000 | -62.2% | 34,393 | -6.5% | 0.00% | – |
| Q1 2022 | $90,000 | -28.6% | 36,777 | -21.9% | 0.00% | – |
| Q4 2021 | $126,000 | -39.4% | 47,090 | +13.3% | 0.00% | – |
| Q3 2021 | $208,000 | -31.6% | 41,554 | +2.1% | 0.00% | – |
| Q2 2021 | $304,000 | -40.2% | 40,689 | -53.0% | 0.00% | – |
| Q1 2021 | $508,000 | +209.8% | 86,509 | +148.5% | 0.00% | – |
| Q4 2020 | $164,000 | – | 34,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |